Skip to content

Tao Capital Management LP

Follow

13F filer, CIK 1802967, SAN FRANCISCO, CA

Tao Capital Management LP reported $116,179,016 across 8 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001802967-26-000001

Period
2025-12-31
Reported value
$116M
Holdings
8
Top 10 weight
100%
New
0
Sold out
2

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MDGLreduced-20,000-$11.6M
OUSTreduced-280,000-$6.06M
SONDQexited-80,188-$102K
DNAexited-5,683-$82.9K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001802967-26-000001, largest first. % of portfolio is the value over $116,179,016, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 86,250 shares; 2024Q4: 86,250 shares; 2025Q1: 86,250 shares; 2025Q2: 86,250 shares; 2025Q3: 86,250 shares; 2025Q4: 86,250 shares 86,250$38.8M33.39%0Timeline
TWSTTWIST BIOSCIENCE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 828,815 shares; 2024Q4: 828,815 shares; 2025Q1: 828,815 shares; 2025Q2: 828,815 shares; 2025Q3: 828,815 shares; 2025Q4: 828,815 shares 828,815$26.3M22.63%0Timeline
OUSTOUSTER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,125,316 shares; 2024Q4: 1,125,316 shares; 2025Q1: 1,125,316 shares; 2025Q2: 1,125,316 shares; 2025Q3: 1,125,316 shares; 2025Q4: 845,316 shares 845,316$18.3M15.75%-280,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 130,529 shares; 2024Q4: 130,529 shares; 2025Q1: 112,785 shares; 2025Q2: 112,785 shares; 2025Q3: 41,000 shares; 2025Q4: 21,000 shares 21,000$12.2M10.53%-20,000Timeline
HHYATT HOTELS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,000 shares; 2024Q4: 70,000 shares; 2025Q1: 70,000 shares; 2025Q2: 70,000 shares; 2025Q3: 70,000 shares; 2025Q4: 70,000 shares 70,000$11.2M9.66%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,862 shares; 2025Q4: 210,862 shares 210,862$3.44M2.96%0Timeline
MASS908 DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 568,981 shares; 2024Q4: 568,981 shares; 2025Q1: 568,981 shares; 2025Q2: 568,981 shares; 2025Q3: 568,981 shares; 2025Q4: 568,981 shares 568,981$2.99M2.57%0Timeline
WRBYWARBY PARKER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 134,473 shares; 2024Q4: 134,473 shares; 2025Q1: 134,473 shares; 2025Q2: 134,473 shares; 2025Q3: 134,473 shares; 2025Q4: 134,473 shares 134,473$2.93M2.52%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SONDQSONDER HLDGS INC CL A NEW80,188$102Kshares
DNAGINKGO BIOWORKS HOLDINGS INC5,683$82.9Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001802967-26-000001 base2026-02-17acceptance time not in the bulk data set